Pseudo—Half-Knot Formation with RNA
David J. Ecker(University of Colorado Denver), Maryann C. Zounes(Ionis Pharmaceuticals (United States)), Timothy A. Vickers(Ionis Pharmaceuticals (United States)), T. W. Bruice(Ionis Pharmaceuticals (United States)), Sandra Freier(Ionis Pharmaceuticals (United States)), Muthiah Manoharan(Alnylam Pharmaceuticals (United States)), R. D. Jenison(Ionis Pharmaceuticals (United States))
Cited by 94
Related Papers
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
A Multiubiquitin Chain Is Confined to Specific Lysine in a Targeted Short-Lived Protein
|Science|1989|1.5k
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
|Angewandte Chemie International Edition|2012|1.2k
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
|Molecular Therapy|2010|1.2k